Use of nabilone in the treatment of chemotherapy-induced vomiting in an outpatient setting

Cancer Treatment Reviews

Volumn 9, Issue SUPPL. 2, 1982, Pages 63-70

  Cone, Lawrence A ^a   Greene, Debra S ^a   Helm, Nicola A ^a  

^a EISENHOWER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENDECLIN; BENINE; BENZQUINAMIDE; BUCLADIN; BUCLIZINE; CHLORMETHINE; CHLORPROMAZINE; CISPLATIN; CYCLIZINE; DIMENHYDRINATE; DIPHENHYDRAMINE 8 BROMOTHEOPHYLLINATE; DOXORUBICIN; DOXYLAMINE; DRONABINOL; DROPERIDOL; EMETROL; FLUPHENAZINE; HALOPERIDOL; MECLOZINE; MEPYRAMINE; MEREZINE; METOCLOPRAMIDE; NABILONE; NEGLAN; PERPHENAZINE; PROCHLORPERAZINE; PROCHLORPERAZINE MALEATE; PROMAZINE; PROMETHAZINE; SPANINE; STREPTOZOCIN; THIETHYLPERAZINE; THIETHYLPERAZINE MALEATE; TRIFLUOPERAZINE; TRIFLUPROMAZINE; TRIMETHOBENZAMIDE; UNCLASSIFIED DRUG; VERPRIN; WANS;

ADVERSE DRUG REACTION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG THERAPY; DYSPHORIA; EMETROL; HUMAN; PREVENTION; THERAPY; VOMITING;

AMBULATORY CARE; ANTIEMETICS; ANTINEOPLASTIC AGENTS; HUMAN; TETRAHYDROCANNABINOL; VOMITING;

EID: 0020306101     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(82)80038-8     Document Type: Article

References (37)

1. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion
2. Emetic action of nitrogen mustard (mechlorethamine hydrochloride) in dogs and cats
3. Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective randomized evaluation
4. A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving Adriamycin and Cytoxan chemotherapy
5. A critical review of the safety and antiemetic efficacy of delta-9-tetrahydrocannabinol
6. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy
7. Delta-9-tetrahydrocannabinol: comments on antiemetic trials
8. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol
9. Mallory-Weiss lesion following cancer chemotherapy
10. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo
11. Isolation, structure, and partial synthesis of an active constituent of hashish
12. Two-prolonged study of tetrahydrocannabinol (THC) prevention of vomiting from cancer chemotherapy
13. Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting
14. Superiority of Nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy
15. Antiemetic cannabinol with minimal euphoria
16. Delta-9-tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancer chemotherapy: a double-blind crossover trial against placebo
17. Clinical pharmacology of nabilone, a cannabinol derivative
18. Suppression of cancer chemotherapy-induced vomiting in the cat by nabilone, a synthetic cannabinoid (40465)
19. Delta-9-tetraphydrocannabinol for refractory vomiting induced by cancer chemotherapy
20. A controlled clinical evaluation of antiemetic drugs
21. Nabilone antiemetic crossover study in cancer chemotherapy patients
22. Comparative Trial of the Antiemetic Effects of THC and Haloperidol
23. Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking
24. Antiemetic effect of tetrahydrocannabinol compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis
25. 1 receptors in the rat brain: an autoradiographic study
26. Combination antiemetics
27. Antiemetics in patients receiving chemotherapy for cancer. A randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine
28. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy
29. Metoclopramide
30. The control of chemotherapy-induced emesis
31. Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis
32. Detection of dopamine receptors in the area postrema
33. Δ9-Tetrahydrocannabinol As An Antiemetic For Patients Receiving Cancer Chemotherapy. A Pilot Study
34. Autoradiographic localization of muscarinic cholinergic receptors in rat brain stem
35. Cancer treatment needs better antiemetics
36. Antiemetics for patients treated with antitumor chemotherapy